{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"XOMA Royalty Corporation"},"Symbol":{"label":"Symbol","value":"XOMAO"},"Address":{"label":"Address","value":"2200 POWELL STREET,SUITE 310, EMERYVILLE, California, 94608, United States"},"Phone":{"label":"Phone","value":"+1 510 204-7200"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes."},"CompanyUrl":{"label":"Company Url","value":"https://www.xoma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bradley J. Sitko","title":"Chief Investment Officer"},{"name":"Owen Patrick Hughes","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}